HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets
Authors
Keywords
-
Journal
Diagnostics
Volume 11, Issue 3, Pages 522
Publisher
MDPI AG
Online
2021-03-16
DOI
10.3390/diagnostics11030522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors for difficult‐to‐treat Hepatitis C Virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan africa
- (2021) Fabienne Shumbusho et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub Saharan Africa and South East Asia
- (2020) Dung Nguyen et al. JOURNAL OF HEPATOLOGY
- Effectiveness of Direct-Acting Antivirals for the treatment of chronic hepatitis C in Rwanda: A retrospective study
- (2020) Sabin Nsanzimana et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Hepatitis C Genotypes 1 to 5 in Sub-Saharan Africa Using Direct-Acting Antivirals
- (2020) Amir Sultan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa
- (2020) Léa Duchesne et al. PLoS One
- Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis
- (2020) Joan Martínez-Campreciós et al. JOURNAL OF VIROLOGICAL METHODS
- Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort
- (2019) Silvia Carlos et al. PLoS One
- Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
- (2019) Alastair Heffernan et al. LANCET
- Utility Of POC Xpert HIV-1 Tests For Detection-Quantification Of Complex HIV Recombinants Using Dried Blood Spots From Kinshasa, D. R. Congo
- (2019) Marina Rubio-Garrido et al. Scientific Reports
- High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supply
- (2019) Daniel Candotti et al. TRANSFUSION
- Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action
- (2019) Neil Gupta et al. JOURNAL OF HEPATOLOGY
- DAA failures in African patients with “unusual” HCV subtypes: Hey! Didn’t you know there was another world?
- (2019) Jean-Michel Pawlotsky JOURNAL OF HEPATOLOGY
- Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
- (2019) Daniel Bradshaw et al. JOURNAL OF INFECTION
- Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
- (2018) Maria C. Sorbo et al. DRUG RESISTANCE UPDATES
- New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings
- (2018) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- Reply to: “Reply to: ‘Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries’”
- (2018) Ana da Silva Filipe et al. JOURNAL OF HEPATOLOGY
- Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r
- (2018) Slim Fourati et al. HEPATOLOGY
- New highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments
- (2018) Chris Davis et al. HEPATOLOGY
- Treatment of hepatitis C virus genotype 4 in the DAA era
- (2018) Antonio Di Biagio et al. Virology Journal
- Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
- (2016) Jean-Michel Pawlotsky GASTROENTEROLOGY
- Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection
- (2016) Armand Abergel et al. HEPATOLOGY
- Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents
- (2016) Prabhav Kalaghatgi et al. PLoS One
- Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms
- (2016) Natalia Chueca et al. PLoS One
- Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
- (2015) Kai-Henrik Peiffer et al. HEPATOLOGY
- Hepatitis C virus drug resistance-associated substitutions: State of the art summary
- (2015) Erik Lontok et al. HEPATOLOGY
- Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring
- (2015) Alexandre Soulier et al. JOURNAL OF INFECTIOUS DISEASES
- High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways
- (2014) Jennifer E. Layden et al. CLINICAL INFECTIOUS DISEASES
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Dried Blood as an Alternative to Plasma or Serum for Trypanosoma cruzi IgG Detection in Screening Programs
- (2013) Africa Holguín et al. Clinical and Vaccine Immunology
- High Frequency of False-Positive Hepatitis C Virus Enzyme-Linked Immunosorbent Assay in Rakai, Uganda
- (2013) C. E. Mullis et al. CLINICAL INFECTIOUS DISEASES
- Poor performance of hepatitis C antibody tests in hospital patients in Uganda
- (2010) E. Seremba et al. JOURNAL OF MEDICAL VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started